Ursprung des Netzwerks ersten Grades von Christine Welch
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 9 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Christine Welch
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| ALZA CORPORATION | Pharmaceuticals: Major | Founder Corporate Officer/Principal | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
Cygnus, Inc.
 Cygnus, Inc. Medical SpecialtiesHealth Technology Cygnus, Inc. develops and manufactures glucose-monitoring devices. The company develops devices that provide data to individuals and physicians to enable them to manage diabetes. It was founded in 1985 and is headquartered in San Francisco, CA. | Medical Specialties | Corporate Officer/Principal | |
| NEKTAR THERAPEUTICS | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| AMARIN CORPORATION PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Allos Therapeutics, Inc.
 Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | Pharmaceuticals: Major | Director/Board Member | |
| CORCEPT THERAPEUTICS INCORPORATED | Pharmaceuticals: Major | Director/Board Member | |
Kaleo, Inc.
 Kaleo, Inc. Pharmaceuticals: MajorHealth Technology Kaleo, Inc. develops drug/device combination products. Its products empower patients to gain freedom from their medical condition. The firm's capabilities include drug development, device development, regulatory and clinical, manufacturing, commercialization and data generation. The company was founded by Eric S. Edwards and Evan T. Edwards in 2005 and is headquartered in Richmond, VA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| KYTHERA BIOPHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member | |
| ABBVIE INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Stanford University | College/University | Masters Business Admin | |
| UCB | Pharmaceuticals: Major | President | |
| University of Missouri | College/University | Undergraduate Degree | |
Eli Lilly Canada, Inc.
 Eli Lilly Canada, Inc. Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Eli Lilly Canada, Inc. is a healthcare leader that focuses on oncology, diabetes, autoimmunity, neurodegeneration, and pain. The company is based in Scarborough, Canada. Established in 1938, the Canadian company collaborates with scientists to produce innovative medicines that make life better for people around the world. The company's mission is to discover and bring life-changing medicines to people who need them, improve the understanding and management of disease, and contribute to communities through philanthropy and volunteerism. | Pharmaceuticals: Major | Sales & Marketing | |
DuPont Merck Pharmaceutical Co.
 DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Powderject Technologies BV | Corporate Officer/Principal | ||
| ACCURAY INCORPORATED | Medical Specialties | Compliance Officer | |
| Colgate University | College/University | Undergraduate Degree | |
| Indiana University-Purdue University | College/University | Undergraduate Degree | |
| Swarthmore College | College/University | Director/Board Member | |
| Pepperdine University | College/University | Masters Business Admin | |
| Santa Clara University | College/University | Undergraduate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree | |
| University of California, Davis | College/University | Doctorate Degree | |
| The University of Colorado | College/University | Graduate Degree Undergraduate Degree | |
| Utah State University | College/University | Doctorate Degree | |
UCB Pharma, Inc.
 UCB Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services UCB Pharma, Inc. provides research, development & commercialisation of pharmeceutical and biotechnology products. Its products are Keppra, Xyzal, Atarax, Lortab, Dipentum, and Tussionex. UCB Pharma develops small and large molecule treatments for a variety of diseases and ailemts. The company was founded by Emmanuel Janssen in 1928 and is headquartered in Smyrna, GA. | Miscellaneous Commercial Services | President | |
| The United States Army (District of Columbia) | Sovereign | Corporate Officer/Principal | |
Symphony Capital LLC
 Symphony Capital LLC Investment ManagersFinance Symphony Capital LLC (Symphony Capital) is a private equity firm founded in 2002. The firm is headquartered in New York. | Investment Managers | Founder | |
The Pitcairn Trust Co.
 The Pitcairn Trust Co. Investment ManagersFinance The Pitcairn Trust Co. is one of the preeminent multi-family offices, dedicated to helping families protect and grow their substantial financial assets and unique heritage across multiple generations. Pitcairn has been recognized as an innovator and leader in the multi-family office space since its inception in 1923. It delivers objective advice and customized services. | Investment Managers | Chief Executive Officer | |
| Syntex Laboratories, Inc. | Sales & Marketing | ||
| United States Navy (District of Columbia) | Sovereign | Corporate Officer/Principal | |
| Powderject Pharmaceuticals, Inc. | Corporate Officer/Principal | ||
| Wilkerson Partners LLC | Founder | ||
aiHit Ltd.
 aiHit Ltd. Data Processing ServicesTechnology Services aiHit Ltd. provides business information services and solutions. It develops and operates search engines. The firm's engine automatically identifies corporate web-sites and extracts structured data from sites to create a profile including a description of the organization, the names and titles of key executives, contact information, clients, and investors. The company was founded by Alan David Hambrook and Eric Sandler on June 22, 2007 and is headquartered in Staines-upon-Thames, the United Kingdom. | Data Processing Services | Corporate Officer/Principal | |
| CIDARA THERAPEUTICS, INC. | Pharmaceuticals: Other | Corporate Officer/Principal | |
| EIGER BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Linda Crnic Institute for Down Syndrome | College/University | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 44 |
| Irland | 3 |
| Belgien | 2 |
| Kanada | 2 |
| Niederlande | 2 |
Sektoral
| Health Technology | 26 |
| Consumer Services | 13 |
| Technology Services | 3 |
| Government | 3 |
| Finance | 3 |
Operativ
| Corporate Officer/Principal | 29 |
| Director/Board Member | 22 |
| Chief Tech/Sci/R&D Officer | 12 |
| Independent Dir/Board Member | 9 |
| Undergraduate Degree | 8 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Christine Welch
- Unternehmensverbindungen